Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 002

Inclusion Criteria: * Healthy permanent residence 2 years of age and older, the subjects (or their guardians) are able to understand and sign the informed consent; * Healthy male or female by oral history, physical examination and clinical judgment and who complies with vaccination of this product; * Be able to comply with the requirements of clinical trial protocol and immunogenicity examination; * Have no history of vaccination within the past 3 months and vaccination with other products within the last 2 weeks; * Axillary temperature ≤37.0℃. Exclusion Criteria: * Any acute disease, such as: tumor, autoimmunity disease, progressive atherosclerotic disease or diabetes with complication, chronic obstructive pulmonary disease need oxygen uptake, acute or progressive hepatopathy or nephropathy, congestive heart-failure, etc.; * Allergic to vaccines or drugs (history of allergy to any vaccine in the past); * History of neurologic symptom or signs; * Known or suspected (or high risk) impaired or abnormal immune function, e.g.: receive immunosuppressant or immunopotentiator therapy, take immunoglobulin or blood product or plasma extract (except the gastrointestinal tract) within the past 3 months, HIV infection or related disease, etc.; * History of meningitis infection or vaccination of meningococcal vaccine within the past 3 months; * History of receiving other vaccines or immunoglobulin injection or any research drugs; * Any acute disease needing application of antibiotics or anti-virus treatment in the whole body within the past 1 week; * History of fever within the past 3 days (axillary temperature ≥38.0℃); * Participating in another clinical trial; * History of allergy, eclampsia, epilepsy, encephalopathy and mental disease or family disease; * Thrombopenia or other coagulopathy that may cause contraindication to intramuscular injection; * Acute chronic disease (such as Down syndrome, diabetes, sickle cell anemia or neurologic disease, Guillain-Barre Syndrome); * Known or suspected diseases, including: respiratory system disease, acute infection or active stage of chronic disease, SBAV infection of children or mothers, cardiovascular disease, acute hypertension, cancer treatment, skin disease, etc.; * Pregnancy * Any condition that, in the judgment of investigator, may affect trial assessment.